lung cancerhepatocellular carcinomaleukemiamalignanciesautoimmune and inflammatory diseasesacademic institutionsInformadendritic cell-CIK therapycytokine-induced killer (CIK) cell therapyChina
…ry sponsors. Oncology trials are most frequent, particularly in lung cancer, leukemia, and hepatocellular carcinoma, while combinatorial st…